(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
NASA loses contact with its Maven spacecraft orbiting Mars for the past decade - 2Mummified cheetahs found in Saudi caves shed light on lost populations
- 3Former Peruvian President Pedro Castillo sentenced for conspiracy
- 4Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- 5Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- The 1st full moon of 2026 rises tonight! Here's what to expect from January's supermoon Wolf Moon
- New findings suggest atmosphere could exist on exoplanet TOI-561b
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- Exploring the Gig Economy: Examples from Consultants
- Phonetic Associations: A Survey of \Interfacing Worldwide People group\ Language Trade Application
- Focus on Yourself: Wellbeing and Taking care of oneself Practices
- Figuring out the Justification for Separation: To blame and No-Shortcoming
- Flourishing in Retirement: Individual Accounts of Post-Profession Satisfaction
- A Manual for Extravagant Vehicles Available in 2024
